Levetiracetam Normon

Levetiracetam, the active ingredient in Levetiracetam Normon, is an antiepileptic presented as an intravenous solution for intravenous use. It is indicated for the treatment of partial‑onset seizures and generalized seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability in seizure disorders.

Partial‑onset seizures: reduces the frequency and severity of focal seizures. Generalized seizures: helps control tonic‑clonic and other generalized seizure types. Adjunct therapy for epilepsy: used in combination with other antiepileptic agents when monotherapy is insufficient.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Irritability: mood changes or increased agitation. - Nausea: occasional stomach upset. - Nasal congestion: mild upper‑respiratory irritation.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Mood disorders: depression, suicidal thoughts, or aggressive behaviour. - Hematologic abnormalities: low white blood cell or platelet counts. - Hepatic dysfunction: elevated liver enzymes. - Respiratory depression: rare but potentially life‑threatening breathing difficulty. - Anaphylaxis: acute allergic reaction requiring immediate medical attention.

Before initiating therapy, clinicians should assess patient history and monitor for specific concerns.

Renal impairment: adjust dosing in patients with reduced kidney function. Psychiatric history: monitor for mood changes or suicidal ideation. Concomitant CNS depressants: use caution when combined with other sedatives. Pregnancy and lactation: evaluate risk‑benefit as safety data are limited. Drug‑specific monitoring: periodic assessment of liver function and blood counts may be warranted. Store below 25°C: keep in the original container, protect from light and moisture.

Levetiracetam can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam exposure. - Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines): may enhance CNS depression. - Antidepressants (e.g., SSRIs): watch for increased behavioral changes. - Immunosuppressants (e.g., cyclosporine): monitor for altered drug levels.